Cargando…
SGLT-2i and Risk of Malignancy in Type 2 Diabetes: A Meta-Analysis of Randomized Controlled Trials
Background: Currently, the association between sodium-glucose cotransporter 2 inhibitor (SGLT-2i) and malignancy risk has yet to be fully elucidated. This meta-analysis aimed to determine the relationship between SGLT-2i and malignancy risk in type 2 diabetes (T2D) patients. Methods: We searched Pub...
Autores principales: | Shi, Nanjing, Shi, Yetan, Xu, Jingsi, Si, Yuexiu, Yang, Tong, Zhang, Mengting, Ng, Derry Minyao, Li, Xiangyuan, Xie, Fei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8215266/ https://www.ncbi.nlm.nih.gov/pubmed/34164370 http://dx.doi.org/10.3389/fpubh.2021.668368 |
Ejemplares similares
-
Relationship Between SGLT-2i and Ocular Diseases in Patients With Type 2 Diabetes Mellitus: A Meta-Analysis of Randomized Controlled Trials
por: Zhou, Bin, et al.
Publicado: (2022) -
Comparison of Minimally Invasive Versus Abdominal Radical Hysterectomy for Early-Stage Cervical Cancer: An Updated Meta-Analysis
por: Zhang, Mengting, et al.
Publicado: (2022) -
The association between caffeine exposure during pregnancy and risk of gestational hypertension/preeclampsia: A meta‐analysis and systematical review
por: Chen, Bangsheng, et al.
Publicado: (2022) -
Development and assessment of novel machine learning models to predict medication non-adherence risks in type 2 diabetics
por: Li, Mengting, et al.
Publicado: (2022) -
Understanding spatiotemporal symptom onset risk of Omicron BA.1, BA.2 and hamster-related Delta AY.127
por: Tong, Chengzhuo, et al.
Publicado: (2022)